Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

被引:6
作者
Fernandez-Fernandez, Oscar [1 ]
Alvarez-Cermeno, Jose C. [3 ]
Arbizu-Urdiain, Txomin [4 ]
Arroyo-Gonzalez, Rafael [5 ]
Arnal-Garcia, Carmen [6 ]
Casanova-Estruch, Bonaventura [7 ]
Carmen Calles-Hernandez, M. [8 ]
Coret-Ferrer, Francisco [9 ]
Comabella-Lopez, Manuel [2 ]
Garcia-Merino, Juan A. [10 ]
de las Heras, Virginia [5 ]
Izquierdo, Guillermo [11 ]
Meca-Lallana, Jose E. [12 ]
Munoz-Garcia, Delicias [13 ]
Olascoaga, Javier [14 ]
Oreja-Guevara, Celia [15 ]
Prieto, Jose M. [16 ]
Rodriguez-Antigueedad, Alfredo [17 ]
Tintore, Mar [2 ]
Montalban, Xavier [2 ]
机构
[1] Hosp Univ Carlos Haya, Malaga, Spain
[2] Hosp Univ Vall dHebron, Barcelona, Spain
[3] Hosp Univ Ramon y Cajal, Madrid, Spain
[4] Hosp Univ Bellvitge, Barcelona, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp Virgen de las Nieves, Granada, Spain
[7] Hosp La Fe, E-46009 Valencia, Spain
[8] Hosp Univ Son Dureta, Palma De Mallorca, Spain
[9] Hosp Clin Univ, Valencia, Spain
[10] Hosp Univ Puerta de Hierro, Madrid, Spain
[11] Hosp Univ Virgen Macarena, Seville, Spain
[12] Hosp Virgen Arrixaca, Murcia, Spain
[13] Hosp Xeral Cies, Vigo, Pontevedra, Spain
[14] Hosp Donostia, San Sebastian, Spain
[15] Hosp Univ La Paz, Madrid, Spain
[16] Hosp Clin Univ, Santiago De Compostela, A Coruna, Spain
[17] Hosp Basurto, Bilbao, Spain
关键词
Diagnosis; ECTRIMS; Genetics; Multiple sclerosis; Progression; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; GLATIRAMER ACETATE; BETA LIGAND; INFLAMMATION;
D O I
10.33588/rn.5204.2010782
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The new insights presented at European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in the city of Gothenburg, Sweden, in October 2010, have been summarized at the third edition of Post-ECTRIMS meeting held in Madrid in November 2010. The age is an important factor related to the course and prognosis of multiple sclerosis (MS). The evolution to progressive disease persists more than 50 years after diagnosis of MS and a reduction in the delay of diagnosis has been detected. Several strategies have been proposed in order to improve the efficacy of magnetic resonance regarding prognosis and course of disease. The studies presented at the Congress reflect the influence of gender on course and severity of disease symptoms, showing an increase of worldwide prevalence of MS in women. Neuroprotective action of estrogen receptor beta has been reported. The genome wide association studies have allowed investigators to identify numerous susceptible alleles. In this regard, HLA class II genes, seems to contribute to genetic risk for developing neutralizing antibodies against beta-interferon. Vitamin D deficiency and Epstein-Barr virus have been highlighted as risk factors for MS in the reported findings. On the subject of the ongoing controversy regarding the role of inflammation and degeneration in MS, several arguments have been found to support the role of CNS autoimmunity to explain the presence of inflammatory phenomenon. The available data hold the potential therapeutic role of mesenchymal cells given the involvement of these stem cells in CNS repair.
引用
收藏
页码:227 / 238
页数:12
相关论文
共 33 条
  • [1] Baarnhielm M, 2010, MULT SCLER, V16, pS7
  • [2] Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis
    Bai, Lianhua
    Lennon, Donald P.
    Eaton, Valerie
    Maier, Kari
    Caplan, Arnold I.
    Miller, Stephen D.
    Miller, Robert H.
    [J]. GLIA, 2009, 57 (11) : 1192 - 1203
  • [3] Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis
    Begum-Haque, Sakhina
    Sharma, Alok
    Kasper, Isaac R.
    Foureau, David M.
    Mielcarz, Daniel W.
    Haque, Azizul
    Kasper, Lloyd H.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2008, 204 (1-2) : 58 - 65
  • [4] Bentzen J, 2010, MULT SCLER, V16, pS7
  • [5] Butzkueven H, 2010, MULT SCLER, V16, pS7
  • [6] Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination
    Crawford, Daniel K.
    Mangiardi, Mario
    Song, Bingbing
    Patel, Rhusheet
    Du, Sienmi
    Sofroniew, Michael V.
    Voskuhl, Rhonda R.
    Tiwari-Woodruff, Seema K.
    [J]. BRAIN, 2010, 133 : 2999 - 3016
  • [7] Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype
    Dhib-Jalbut, S
    Chen, M
    Said, A
    Zhan, M
    Johnson, KP
    Martin, R
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2003, 140 (1-2) : 163 - 171
  • [8] Ferre JC, 2010, MULT SCLER, V16, pS41
  • [9] Gray matter atrophy is related to long-term disability in multiple sclerosis
    Fisniku, Leonora K.
    Chard, Declan T.
    Jackson, Jonathan S.
    Anderson, Valerie M.
    Altmann, Daniel R.
    Miszkiel, Katherine A.
    Thompson, Alan J.
    Miller, David H.
    [J]. ANNALS OF NEUROLOGY, 2008, 64 (03) : 247 - 254
  • [10] Fisniku LK, 2010, MULT SCLER, V16, pS7